Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis
Richard J. Miron(University of Southern California), Anton Sculean(University of Bern), Hom‐Lay Wang(University of Michigan), Masako Fujioka‐Kobayashi(University of Bern), Yoshinori Shirakata(Kagoshima University), Ferenc Döri(Semmelweis University), Vittório Moraschini(Universidade Veiga de Almeida), Reinhard Gruber(University of Bern), Søren Jepsen(University of Bonn), Mark Bishara, Tomoyuki Kawase(Niigata University), Luigi Canullo, Raluca Cosgarea(Iuliu Hațieganu University of Medicine and Pharmacy), Yufeng Zhang(Wuhan University), Mônica Diuana Calasans‐Maia(Universidade Federal Fluminense)
Cited by 174
Related Papers
Peri‐implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions
|Journal Of Clinical Periodontology|2018|1.6k
Peri‐implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions
|Journal of Periodontology|2018|871
Comparative release of growth factors from PRP, PRF, and advanced-PRF
|Clinical Oral Investigations|2016|775
Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?
|Clinical Oral Investigations|2017|556
Use of platelet-rich fibrin in regenerative dentistry: a systematic review
|Clinical Oral Investigations|2017|518